5 February 2019
Experts Propose Revising the Criteria for Diagnosis of Parkinson's Disease with a View Towards Earlier Treatment and Prevention
Amsterdam, NL – In the past 25 years, it has become clear that some symptoms of Parkinson's disease occur decades before the development of motor symptoms and clinical diagnosis, and that monitoring these emerging symptoms may provide important insights into the origin and development of the disease.
31 January 2019
The Search for Environmental Causes of Parkinson's Disease Moves Forward
Amsterdam, NL – Environmental factors are widely believed to play a key role in the development of Parkinson's disease (PD), but little is known about specific environmental triggers. Writing in a supplement to the Journal of Parkinson's Disease, scientists review novel research hypotheses and approaches that may help better define the role of environment in the development of PD, especially before a diagnosis can be made based on the characteristic motor dysfunction for which PD is known.
29 January 2019
Emerging Evidence of an Impending Parkinson’s Disease Pandemic Identified
Amsterdam, NL – For most of human history Parkinson's disease (PD) has been a rare disorder. However, demography and the by-products of industrialization are now contributing to an impending a Parkinson’s pandemic, according to experts writing in a supplement to JPD.
20 December 2018
Parkinson’s Disease Experts Devise a Roadmap for Developing Drugs Targeting Alpha-Synuclein
Amsterdam, NL – A recently discovered protein, alpha-synuclein, has become one of the most attractive targets for developing new drugs with the potential to slow down or arrest the progression of Parkinson’s disease (PD).
24 September 2018
Optimizing Dopaminergic Treatment Improves Non-Motor Symptoms in Severe Parkinson’s Disease
Amsterdam, NL – Non-motor symptoms are common in late stage Parkinson’s disease (PD) as the frequency and severity of most of these symptoms increase with advancing disease.
24 September 2018
Eradicating Helicobacter pylori Infections May Be a Key Treatment for Parkinson's Disease
Amsterdam, NL – While human genetic mutations are involved in a small number of Parkinson’s disease (PD) cases, the vast majority of cases are of unknown environmental causes, prompting enormous interest in identifying environmental risk factors involved.
10 September 2018
Parkinson Matters: A Call to Action to Improve Patient Care
Amsterdam, NL – Deaths associated with Parkinson’s disease and related disorders increased substantially between 2001 and 2014. Parkinson’s disease was in fact the most common cause of death associated with a neurological condition, according to a report by Public Health England.
3 August 2018
Insulin Resistance Under-Diagnosed in Non-Diabetics with Parkinson’s Disease
Almost two-thirds of non-diabetic patients with Parkinson’s disease (PD) may be insulin resistant, despite having normal blood sugar, report scientists in the Journal of Parkinson’s Disease.
1 August 2018
Exenatide Treatment Alleviated Symptoms of Depression in Patients with Moderate Parkinson’s Disease
Non-motor symptoms of Parkinson’s disease (PD), such as depression, apathy, cognitive impairment, sleep disorders, and sensory symptoms, can have a greater impact on health-related quality of life than motor deficits.
26 June 2018
Video of the Inaugural Parkinson's Webinar Available: Does Exenatide Reduce Non-Montor Symptoms?
A brand new Quarterly Parkinson's Webinar Series, delivered by JPD, CPT and Parkinson's Movement, sees the the discussion of specific Parkinson's disease research topics is brought into the open. The first webinar in our quarterly series took place on June 19, 2018 with a focus on exenatide, and the recording can now be viewed online.
Pages
